Final report: Phase I trial of imatinib mesylate, hydroxyurea, and vatalanib for patients with recurrent malignant glioma (MG)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kirkpatrick, JP; Rich, JN; Vredenburgh, JJ; Desjardins, A; Quinn, JA; Gururangan, S; Sathornsumetee, S; Egorin, MJ; Friedman, HS; Reardon, DA

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Language

  • English